Company Valuation: ResMed, Inc.

Data adjusted to current consolidation scope
Fiscal Period: June 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 27,776 35,903 30,691 32,133 28,117 37,561 - -
Change - 29.26% -14.52% 4.7% -12.5% 33.59% - -
Enterprise Value (EV) 1 28,489 36,263 31,192 33,346 28,585 37,165 36,280 35,267
Change - 27.29% -13.98% 6.9% -14.28% 30.01% -2.38% -2.79%
P/E ratio 45x 76.1x 39.6x 35.9x 27.7x 27.6x 25.1x 22.8x
PBR 11.1x 12.4x 9.35x 7.76x 5.78x 6.53x 5.56x 4.77x
PEG - -3.2x 0.6x 2.4x 2x 0.8x 2.5x 2.2x
Capitalization / Revenue 9.39x 11.2x 8.58x 7.61x 6x 7.33x 6.77x 6.3x
EV / Revenue 9.63x 11.3x 8.72x 7.9x 6.1x 7.25x 6.54x 5.92x
EV / EBITDA 29.5x 33.8x 26.8x 25.3x 18.1x 19.9x 17.7x 15.8x
EV / EBIT 35.1x 40.1x 31.2x 27.2x 19.3x 21.4x 18.8x 16.8x
EV / FCF 40.3x 57.2x 144x 58.1x 22x 26.8x 24.1x 21.5x
FCF Yield 2.48% 1.75% 0.69% 1.72% 4.55% 3.73% 4.14% 4.64%
Dividend per Share 2 1.56 1.56 1.68 1.8 1.92 2.158 2.498 2.533
Rate of return 0.81% 0.63% 0.8% 0.82% 1% 0.84% 0.97% 0.99%
EPS 2 4.27 3.24 5.3 6.09 6.92 9.288 10.22 11.27
Distribution rate 36.5% 48.1% 31.7% 29.6% 27.7% 23.2% 24.4% 22.5%
Net sales 1 2,957 3,197 3,578 4,223 4,685 5,126 5,546 5,959
EBITDA 1 966 1,074 1,162 1,317 1,576 1,863 2,050 2,225
EBIT 1 811.2 903.7 1,000 1,224 1,478 1,738 1,927 2,098
Net income 1 621.7 474.5 779.4 897.6 1,021 1,363 1,507 1,675
Net Debt 1 713 360.1 501.5 1,213 468.9 -395.8 -1,281 -2,294
Reference price 2 192.00 246.52 209.63 218.50 191.42 256.59 256.59 256.59
Nbr of stocks (in thousands) 1,44,668 1,45,640 1,46,405 1,47,062 1,46,884 1,46,385 - -
Announcement Date 05/08/20 05/08/21 11/08/22 03/08/23 01/08/24 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
27.63x7.25x19.95x0.84% 3.76TCr
75.08x18.92x46.96x-.--% 19TCr
24.2x4.22x16.96x0.39% 16TCr
53.42x8.16x27.4x-.--% 15TCr
34.67x6.3x20.11x0.6% 14TCr
23.02x2.74x13.35x2.23% 6.12TCr
31.57x7.03x23.68x-.--% 4.48TCr
20.85x6.05x16.19x3.11% 3.66TCr
18.23x1.95x11.61x0.18% 3.44TCr
26.72x5.31x17.8x0.81% 3.44TCr
Average 33.54x 6.79x 21.40x 0.82% 8.94TCr
Weighted average by Cap. 41.75x 8.52x 25.59x 0.52%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. RMD Stock
  4. Valuation ResMed, Inc.